Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Selected Balance Sheet Data

v3.10.0.1
Note 3 - Selected Balance Sheet Data
6 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Supplemental Balance Sheet Disclosures [Text Block]
N
ote
3
. Selected Balance Sheet Data
:
 
Inventories:
 
Inventories consist of (in thousands):
 
   
December 31,
2018
   
June 30,
2018
 
Raw materials
  $
35,253
    $
30,956
 
Finished goods
   
55,652
     
54,692
 
Inventories, net
  $
90,905
    $
85,648
 
 
 
Property and Equipment:
 
Property and equipment consist of (in thousands): 
 
   
December 31,
   
June 30,
 
   
2018
   
2018
 
Land
  $
7,065
    $
7,065
 
Buildings and improvements
   
170,772
     
170,110
 
Machinery and equipment
   
118,487
     
107,625
 
Property and equipment, cost
   
296,324
     
284,800
 
Accumulated depreciation and amortization
   
(151,062
)    
(139,452
)
Property and equipment, net
  $
145,262
    $
145,348
 
 
Intangible Assets:
 
Intangible assets consist of (in thousands): 
 
   
December 31,
   
June 30,
 
   
2018
   
2018
 
Developed technology
  $
497,546
    $
305,303
 
Trade names
   
88,988
     
89,608
 
Customer relationships
   
209,674
     
212,228
 
Patents
   
1,850
     
1,401
 
Intangible assets
   
798,058
     
608,540
 
Accumulated amortization
   
(189,785
)    
(162,208
)
Intangible assets, net
  $
608,273
    $
446,332
 
 
Changes to the carrying amount of net intangible assets for the
six
months ended
December 31, 2018
consist of (in thousands):
 
Beginning balance
  $
446,332
 
Acquisitions
   
193,400
 
Other additions
   
409
 
Amortization expense
   
(29,354
)
Currency translation
   
(2,514
)
Ending balance
  $
608,273
 
 
The estimated future amortization expense for intangible assets as of
December 31, 2018
is as follows (in thousands):
 
2019 (remainder)
  $
30,193
 
2020
   
59,752
 
2021
   
59,406
 
2022
   
57,746
 
2023
   
55,871
 
Thereafter
   
345,305
 
Total
  $
608,273
 
 
 
Goodwill:
 
Changes to the carrying amount of goodwill for the
six
months ended
December 31, 2018
consist of (in thousands):
 
   
Protein Sciences
   
Diagnostics and Genomics
   
Total
 
Beginning balance
  $
347,918
    $
249,972
    $
597,890
 
Acquisitions (Note 4)
   
13,554
     
99,027
     
112,581
 
Currency translation
   
(4,061
)    
(55
)    
(4,116
)
Ending balance
  $
357,411
    $
348,944
    $
706,355
 
 
We evaluate the carrying value of goodwill in the
fourth
quarter of each fiscal year and between annual evaluations if events occur or circumstances change that would indicate a possible impairment. The Company performed a quantitative assessment for all of its reporting units during the
fourth
quarter of fiscal
2018.
The quantitative assessment indicated that all of the reporting units had substantial headroom as of
June 30, 2018.
 
No
triggering events were identified during the
six
months ended
December 31, 2018.
There has been
no
impairment of goodwill since the adoption of Financial Accounting Standards Board (“FASB”) ASC
350
guidance for goodwill and other intangibles on
July 1, 2002.